Terumo (OTCMKTS:TRUMY) Shares Gap Down – Time to Sell?

Terumo Corp. (OTCMKTS:TRUMY)’s stock price gapped down before the market opened on Thursday. The stock had previously closed at $14.66, but opened at $13.92. Terumo shares last traded at $13.92, with a volume of 9,557 shares traded.

Analyst Upgrades and Downgrades

Separately, Nomura raised shares of Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, Terumo presently has an average rating of “Buy”.

Terumo Trading Down 6.4%

The firm’s 50 day simple moving average is $15.17 and its 200-day simple moving average is $14.19. The company has a quick ratio of 1.37, a current ratio of 2.19 and a debt-to-equity ratio of 0.13. The company has a market capitalization of $20.25 billion, a PE ratio of 19.34 and a beta of 0.77.

Terumo (OTCMKTS:TRUMY) last announced its quarterly earnings results on Friday, August 7th. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.13. Terumo had a return on equity of 10.44% and a net margin of 13.83%.The firm had revenue of $1.97 billion during the quarter, compared to the consensus estimate of $1.84 billion. As a group, equities research analysts anticipate that Terumo Corp. will post 0.86 EPS for the current year.

About Terumo

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other healthcare settings. Founded in 1921 by a group of Japanese medical doctors, the company initially produced clinical thermometers and has since expanded into a global provider of medical devices and related services.

Terumo’s principal businesses include cardiac and vascular products, blood and cell technologies, and general hospital solutions.